In vitro activity of mastoparan-AF alone and in combination with clinically used antibiotics against multiple-antibiotic-resistant Escherichia coli isolates from animals

被引:21
|
作者
Lin, Chun-Hsien [1 ]
Hou, Roger F. [1 ]
Shyu, Ching-Lin [2 ,3 ]
Shia, Wei-Yau [2 ]
Lin, Chuen-Fu [4 ]
Tu, Wu-Chun [1 ]
机构
[1] Natl Chung Hsing Univ, Dept Entomol, Taichung 40227, Taiwan
[2] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan
[3] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan
[4] Cent Taiwan Univ Sci & Technol, Dept Med Lab Sci & Biotechnol, Taichung 40601, Taiwan
关键词
Mastoparan-AF; Antimicrobial resistance gene; Antimicrobial activity; Antibiotic; E; coli; Synergism; ANTIMICROBIAL-RESISTANCE; BETA-LACTAMASES; KLEBSIELLA-PNEUMONIAE; GENE PROFILES; PEPTIDES; AGENTS; MECHANISMS; VENOM; CHLORAMPHENICOL; PREVALENCE;
D O I
10.1016/j.peptides.2012.03.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The in vitro activity of mastoparan-AF, an amphipathic antimicrobial peptide isolated from the hornet venom of Vespa affinis, alone and in combination with various clinically used antibiotics, was investigated against 21 Escherichia coli isolates/strains. Most E. coli isolates tested were detected containing multiple-antimicrobial resistance genes. Antimicrobial activity of mastoparan-AF was measured by MIC, MBC, time-kill kinetic assay and chequerboard titration method. Mastoparan-AF exhibited potent antimicrobial activity against most multiple-antibiotic-resistant E. coli isolates at the concentrations ranging from 4 to 16 mu g/ml. Combination studies showed that mastoparan-AF acts synergistically with certain antibiotics, i.e., cephalothin or gentamicin, against some multiple-antibiotic-resistant E. coli isolates. In conclusion, mastoparan-AF alone or in combination with other antibiotics could be promising as alternatives for combating multiple-antibiotic-resistant E. coli in future clinical applications. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 120
页数:7
相关论文
共 21 条
  • [1] Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii
    Lin, Chun-Hsien
    Lee, Mong-Chuan
    Tzen, Jason T. C.
    Lee, Hsien-Ming
    Chang, Sam-Min
    Tu, Wu-Chun
    Lin, Chuen-Fu
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2017, 24 (05) : 1023 - 1029
  • [2] Investigation into combination of an antimicrobial peptide with existing antibiotics against antibiotic resistant clinical isolates of Escherichia coli
    Y Hu
    J Shallop
    Y Liu
    A Coates
    [J]. Antimicrobial Resistance and Infection Control, 4 (Suppl 1)
  • [3] Fosfomycin Resistance in Escherichia coli Isolates from South Korea and in vitro Activity of Fosfomycin Alone and in Combination with Other Antibiotics
    Seok, Hyeri
    Choi, Ji Young
    Wi, Yu Mi
    Park, Dae Won
    Peck, Kyong Ran
    Ko, Kwan Soo
    [J]. ANTIBIOTICS-BASEL, 2020, 9 (03):
  • [4] In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates
    Celenza, Giuseppe
    Segatore, Bernardetta
    Setacci, Domenico
    Bellio, Pierangelo
    Brisdelli, Fabrizia
    Piovano, Marisa
    Garbarino, Juan A.
    Nicoletti, Marcello
    Perilli, Mariagrazia
    Amicosante, Gianfranco
    [J]. PHYTOMEDICINE, 2012, 19 (07) : 596 - 602
  • [5] In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli
    Wang, Yale
    Li, He
    Xie, Xiaoqian
    Wu, XiaoHan
    Li, Xinxin
    Zhao, Zeyue
    Luo, Shasha
    Wan, Zhijie
    Liu, Jingjing
    Fu, Lei
    Li, Xiaotian
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 20 : 351 - 359
  • [6] In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs
    Lautzenhiser, SJ
    Fialkowski, JP
    Bjorling, D
    Rosin, E
    [J]. RESEARCH IN VETERINARY SCIENCE, 2001, 70 (03) : 239 - 241
  • [7] In Vitro Activity and Pharmacodynamics of Commonly Used Antibiotics Against Adult Systemic Isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals
    Eagye, Kathryn J.
    Kuti, Joseph L.
    Sutherland, Christina A.
    Christensen, Henry
    Nicolau, David P.
    [J]. CLINICAL THERAPEUTICS, 2009, 31 (11) : 2678 - 2688
  • [8] TAUROLIDINE - IN-VITRO ACTIVITY AGAINST MULTIPLE-ANTIBIOTIC-RESISTANT, NOSOCOMIALLY SIGNIFICANT CLINICAL ISOLATES OF STAPHYLOCOCCUS-AUREUS, ENTEROCOCCUS-FAECIUM, AND DIVERSE ENTEROBACTERIACEAE
    TRAUB, WH
    LEONHARD, B
    BAUER, D
    [J]. CHEMOTHERAPY, 1993, 39 (05) : 322 - 330
  • [9] In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals
    Cengiz, M.
    Sahinturk, P.
    Sonal, S.
    Buyukcangaz, E.
    Sen, A.
    Arslan, E.
    [J]. VETERINARY RECORD, 2013, 172 (18) : 474 - +
  • [10] In vitro activity of honey, total alkaloids of Sophora alopecuroides and matrine alone and in combination with antibiotics against multidrug-resistant Pseudomonas aeruginosa isolates
    Jaktaji, R. Pourahmad
    Koochaki, S.
    [J]. LETTERS IN APPLIED MICROBIOLOGY, 2022, 75 (01) : 70 - 80